2-Methoxy-4-(4-Acetylpiperazinyl)Aniline Bulk Price 2026
- Market Outlook: 2026 forecasts indicate stable pricing for bulk orders driven by optimized synthesis routes.
- Purity Standards: Industrial purity levels exceeding 98% are available for GMP-compliant manufacturing.
- Procurement: Tiered pricing structures offer significant cost reductions for kilogram and ton-scale acquisitions.
The pharmaceutical intermediate landscape is evolving rapidly, with specific demand for high-quality aniline derivatives used in kinase inhibitor synthesis. 2-Methoxy-4-(4-acetylpiperazinyl)aniline (CAS: 1021426-42-5) represents a critical building block in the production of advanced therapeutic compounds. As we approach 2026, procurement managers and process chemists must understand the factors influencing bulk price volatility, supply chain reliability, and technical specifications. NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier partner in this sector, ensuring consistent supply chains for global pharmaceutical manufacturers.
Technical Specifications and Synthesis Overview
Understanding the chemical profile is essential for quality control during scale-up. This compound is frequently identified in technical documentation by synonyms such as 4-(4-Acetyl-1-piperazinyl)-2-(methyloxy)aniline or 1-[4-(4-amino-3-methoxyphenyl)piperazin-1-yl]ethanone. The molecular structure features a methoxy-substituted aniline core linked to an acetylated piperazine ring, requiring precise control during nitration and reduction steps to maintain industrial purity.
The synthesis route typically involves the coupling of substituted anilines with acetylpiperazine derivatives under controlled conditions. Reaction yields are highly dependent on solvent selection and temperature regulation. Impurities often arise from incomplete acetylation or over-alkylation, necessitating rigorous purification via crystallization or chromatography. When sourcing high-purity 2-Methoxy-4-(4-acetylpiperazinyl)aniline, buyers should verify that the manufacturing process includes comprehensive analytical validation. Standard testing protocols involve HPLC, NMR, and LC-MS to confirm identity and assay values.
Quality Assurance and Documentation
For regulatory compliance, every batch must be accompanied by a comprehensive COA (Certificate of Analysis). This document verifies parameters such as appearance, melting point, and residual solvent levels. As a global manufacturer, adherence to ISO standards ensures that the material is suitable for downstream API production. Storage conditions generally require inert gas (nitrogen or argon) at 2–8 °C to prevent oxidation of the aniline moiety, preserving stability during long-term warehousing.
Wholesale Pricing Tiers by Volume
Pricing for pharmaceutical intermediates is heavily dependent on order volume and purity requirements. Market data suggests a significant price reduction per unit as volume increases from gram-scale research quantities to multi-kilogram production batches. The following table outlines typical pricing structures observed in the B2B sector for 2026.
| Volume Tier | Purity Grade | Estimated Lead Time | Price Trend (Relative) |
|---|---|---|---|
| 5g - 100g (Research) | 95% - 98% | 1-3 Days | High (Premium) |
| 1kg - 5kg (Pilot) | 98% - 99% | 1-2 Weeks | Moderate |
| 10kg - 50kg (Production) | 99%+ | 3-4 Weeks | Low (Bulk Discount) |
| 100kg+ (Industrial) | Custom Spec | Negotiated | Lowest (Contract) |
Small-scale purchases often incur higher costs due to packaging and quality control overheads. Conversely, bulk procurement allows for optimized reactor usage and reduced logistical friction. NINGBO INNO PHARMCHEM CO.,LTD. offers flexible packaging solutions to accommodate these varying needs, ensuring cost-efficiency for both R&D and commercial manufacturing phases.
Regional Cost Analysis for 2026
The global supply chain for fine chemicals is subject to regional variations in raw material costs and regulatory compliance expenses. In 2026, manufacturers in Asia continue to offer competitive advantages due to integrated supply chains for precursor chemicals. However, logistics and tariffs can impact the landed cost for buyers in North America and Europe.
Market intelligence indicates that prices for piperazine-based intermediates remain stable, provided there are no disruptions in raw material availability. Buyers should anticipate slight fluctuations based on energy costs affecting synthesis operations. Securing long-term contracts with verified suppliers mitigates the risk of spot-market volatility. Furthermore, suppliers offering door-to-door delivery with customs clearance support add significant value, reducing the total cost of ownership for importing firms.
Payment Terms and Logistics
Efficient procurement requires clear agreements on payment and shipping. Standard industry terms often include T/T (Telegraphic Transfer) or L/C (Letter of Credit) for large transactions. Credit terms such as NET 30 or NET 60 may be available for established partners with verified credit histories.
Shipping and Safety Compliance
Safety is paramount during transport. This chemical is typically classified with specific GHS symbols indicating potential hazards such as skin irritation or respiratory sensitivity. Proper labeling and packaging in accordance with international transport regulations are mandatory. Suppliers should provide Safety Data Sheets (SDS) detailing hazard statements (e.g., H315, H319) and precautionary measures.
- Packaging: Double-sealed bags within fiber drums or cartons, often with desiccants to control moisture.
- Transport: Dry ice or blue ice packaging may be required for temperature-sensitive shipments.
- Documentation: Commercial invoice, packing list, and COA must accompany all shipments.
In conclusion, securing a reliable supply of 1-(4-(4-amino-3-methoxy phenyl)piperazin-1-yl)ethanone requires a partner with robust technical capabilities and transparent pricing. By focusing on industrial purity and scalable synthesis, buyers can ensure uninterrupted production flows for their pharmaceutical applications.